These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 17666089

  • 1. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y, Unluhizarci K, Yilmazsoy A, Yikilmaz A, Aygen E, Kelestimur F.
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [Abstract] [Full Text] [Related]

  • 2. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 3. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F, Perini D, Lazzarini V, Parrini D, Gambacciani M, Genazzani AR.
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [Abstract] [Full Text] [Related]

  • 4. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH, von Eye Corleta H, Capp E, Spritzer PM.
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [Abstract] [Full Text] [Related]

  • 5. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J, Hill M, Stárka L, Cibula D, Snajderová M, Sulcová J, Vondra K, Bendlová B.
    Cas Lek Cesk; 2001 Nov 08; 140(22):688-94. PubMed ID: 11789058
    [Abstract] [Full Text] [Related]

  • 6. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Nov 08; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 7. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec 08; 38(12):745-8. PubMed ID: 14728846
    [Abstract] [Full Text] [Related]

  • 8. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 9. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J, Shen H, Li J, Huang Z, Zhang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb 07; 37(2):86-9. PubMed ID: 11953071
    [Abstract] [Full Text] [Related]

  • 10. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct 07; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 11. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun 07; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 12. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 07; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 13. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D.
    Metabolism; 2007 Jan 07; 56(1):129-34. PubMed ID: 17161235
    [Abstract] [Full Text] [Related]

  • 14. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A, Agarwal N.
    J Reprod Med; 2004 May 07; 49(5):361-7. PubMed ID: 15214709
    [Abstract] [Full Text] [Related]

  • 15. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD, Silva Lara LA, Japur de Sá Rosa-e-Silva AC, Ferriani RA, Reis RM.
    Gynecol Endocrinol; 2013 Mar 07; 29(3):246-9. PubMed ID: 23194004
    [Abstract] [Full Text] [Related]

  • 16. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB, Bagis T, Zeyneloglu HB, Tarim E, Aslan E, Haydardedeoglu B, Erkanli S.
    Hum Reprod; 2005 Apr 07; 20(4):894-9. PubMed ID: 15618250
    [Abstract] [Full Text] [Related]

  • 17. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 07; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 18. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 07; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 19. Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.
    Hanjalic-Beck A, Gabriel B, Schaefer W, Zahradnik HP, Schories M, Tempfer C, Keck C, Denschlag D.
    Gynecol Endocrinol; 2010 Sep 07; 26(9):690-7. PubMed ID: 20626240
    [Abstract] [Full Text] [Related]

  • 20. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
    Trolle B, Lauszus FF, Frystyk J, Flyvbjerg A.
    Fertil Steril; 2010 Nov 07; 94(6):2234-8. PubMed ID: 20189560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.